The US Federal Trade Commission (FTC) is suing to halt Amgen from acquiring Horizon Therapeutics. Amgen had announced in December that it would buy the Irish-headquartered biopharma company for almost $28 billion (£22 billion). The FTC is seeking a preliminary injunction from a federal court to stop the merger on the grounds that it would […]
Read More